RT Journal Article
SR Electronic
T1 Rapid protocols to support Covid-19 clinical diagnosis based on hematological parameters
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.21.21259252
DO 10.1101/2021.06.21.21259252
A1 Gomes, Juliana Carneiro
A1 de Freitas Barbosa, Valter Augusto
A1 de Santana, Maíra Araújo
A1 de Lima, Clarisse Lins
A1 Calado, Raquel Bezerra
A1 Bertoldo Júnior, Cláudio Roberto
A1 de Almeida Albuquerque, Jeniffer Emidio
A1 de Souza, Rodrigo Gomes
A1 de Araújo, Ricardo Juarez Escorel
A1 Moreno, Giselle Machado Magalhães
A1 Soares, Luiz Alberto Lira
A1 Mattos Júnior, Luiz Alberto Reis
A1 de Souza, Ricardo Emmanuel
A1 dos Santos, Wellington Pinheiro
YR 2021
UL http://medrxiv.org/content/early/2021/06/28/2021.06.21.21259252.abstract
AB Purpose In December 2019, the Covid-19 pandemic began in the world. To reduce mortality, in addiction to mass vaccination, it is necessary to massify and accelerate clinical diagnosis, as well as creating new ways of monitoring patients that can help in the construction of specific treatments for the disease.Objective In this work, we propose rapid protocols for clinical diagnosis of Covid-19 through the automatic analysis of hematological parameters using Evolutionary Computing and Machine Learning. These hematological parameters are obtained from blood tests common in clinical practice.Method We investigated the best classifier architectures. Then, we applied the particle swarm optimization algorithm (PSO) to select the most relevant attributes: serum glucose, troponin, partial thromboplastin time, ferritin, D-dimer, lactic dehydrogenase, and indirect bilirubin. Finally, we used decision trees to build four rapid protocols for Covid-19 clinical diagnosis.Results We developed a web system for Covid-19 diagnosis support. Using a 100-tree Random Forest, we obtained results for accuracy, sensitivity and specificity superior to 99Conclusion By using a reduced set of hematological parameters common in clinical practice, it was possible to achieve results of accuracy, sensitivity and specificity comparable to those obtained with RT-PCR. It was also possible to automatically generate clinical decision protocols, allowing relatively accurate clinical diagnosis even without the aid of the web decision support system.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Federal University of Pernambuco, Google Cloud COVID-19 Research Grant, and the Brazilian research agencies CAPES and CNPq.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This retrospective study used the medical records of patients provided by the Health Secretariat of the city of Paudalho as a database. All procedures for this research were approved by the Research Ethics Committee at the Federal University of Pernambuco under number CAAE 34932020.3.0000.5208.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available on demand.